Assessing Bleeding Risk With the HAS‐BLED Score: Balancing Simplicity, Practicality, and Predictive Value in Bleeding‐Risk Assessment
Key result
The HAS-BLED score demonstrated superior diagnostic accuracy for major bleeding risk prediction in anticoagulated patients with atrial fibrillation compared to other clinical risk scores.
Why the study?
Does the HAS-BLED score improve bleeding risk prediction compared to other risk scores in anticoagulated patients with atrial fibrillation?
Population
Anticoagulated patients with atrial fibrillation
Comparison
HAS-BLED score for bleeding risk assessment vs Other risk scores
Design
Editorial
Authors
Discussion
Loading...
Member takes
Implication
The HAS-BLED score is superior to other risk scores in predicting bleeding risk in anticoagulated AF patients, balancing simplicity and predictive value while identifying correctable risk factors.
Structured PICO
Does the HAS-BLED score improve bleeding risk prediction compared to other risk scores in anticoagulated patients with atrial fibrillation?
P
Population
Anticoagulated patients with atrial fibrillation
E
Exposure
HAS-BLED score for bleeding risk assessment
C
Comparator
Other risk scores (HEMORR2HAGES, ATRIA, CHADS2, or CHA2DS2-VASc)
O
Outcome
Diagnostic accuracy for major bleeding risk prediction
The HAS-BLED score is superior to other risk scores in predicting bleeding risk in anticoagulated AF patients, balancing simplicity and predictive value while identifying correctable risk factors.
Limitations
- Derivation or validation studies may have used highly selected cohorts or trial datasets that excluded patients with prior severe bleeds or severe renal impairment.
- Derivation or validation studies may have used highly selected cohorts or trial datasets
Cite This Study
Gregory Y.H. Lip (2015) conducted an editorial in Atrial fibrillation. HAS-BLED score vs. HEMORR2HAGES, ATRIA, CHADS2, or CHA2DS2-VASc scores was evaluated on Diagnostic accuracy for bleeding-risk prediction. The HAS-BLED score demonstrated superior diagnostic accuracy for major bleeding risk prediction in anticoagulated patients with atrial fibrillation compared to other clinical risk scores.